An in depth review of our latest understanding of the molecular
events that regulate cell death and those molecules that provide
targets for developing agonists or antagonists to modulate death
signaling for therapeutic purposes. The authors focus on the
extrinsic system of death receptors, their regulation and function,
and their abnormalities in cancer. Topics of particular interest
include resistance to apoptosis, TRAIL signaling, death receptors
in embryonic development, mechanisms of caspase activation, and
death receptor mutations in cancer. Additional chapters address
death signaling in melanoma, synthetic retinoids and death
receptors, the role of p53 in death receptor regulation, immune
suppression of cancer, and combination therapy with death ligands.
General
Imprint: |
HumanaPress
|
Country of origin: |
United States |
Series: |
Cancer Drug Discovery and Development |
Release date: |
November 2010 |
First published: |
2005 |
Editors: |
Wafik S ElDeiry
|
Dimensions: |
254 x 178 x 20mm (L x W x T) |
Format: |
Paperback
|
Pages: |
374 |
Edition: |
Softcover reprint of hardcover 1st ed. 2005 |
ISBN-13: |
978-1-61737-401-2 |
Categories: |
Books >
Medicine >
Clinical & internal medicine >
Diseases & disorders >
Oncology >
General
|
LSN: |
1-61737-401-6 |
Barcode: |
9781617374012 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!